Two Sigma Advisers’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-11,088
| Closed | -$134K | – | 2434 |
|
|
2023
Q2 | $134K | Buy |
11,088
+1,460
| +15% | +$17.7K | ﹤0.01% | 2169 |
|
|
2023
Q1 | $122K | Sell |
9,628
-6,028
| -39% | -$76.7K | ﹤0.01% | 2351 |
|
|
2022
Q4 | $98.9K | Sell |
15,656
-2,307
| -13% | -$14.6K | ﹤0.01% | 2299 |
|
|
2022
Q3 | $405K | Sell |
17,963
-5,181
| -22% | -$117K | ﹤0.01% | 1936 |
|
|
2022
Q2 | $444K | Buy |
23,144
+8,488
| +58% | +$163K | ﹤0.01% | 1972 |
|
|
2022
Q1 | $680K | Buy |
14,656
+1,293
| +10% | +$60K | ﹤0.01% | 1834 |
|
|
2021
Q4 | $947K | Sell |
13,363
-325
| -2% | -$23K | ﹤0.01% | 1581 |
|
|
2021
Q3 | $1.59M | Buy |
13,688
+788
| +6% | +$91.8K | ﹤0.01% | 1375 |
|
|
2021
Q2 | $2.02M | Sell |
12,900
-56
| -0.4% | -$8.77K | 0.01% | 1295 |
|
|
2021
Q1 | $2.45M | Sell |
12,956
-325
| -2% | -$61.6K | 0.01% | 1170 |
|
|
2020
Q4 | $1.67M | Buy |
13,281
+1,637
| +14% | +$205K | ﹤0.01% | 1347 |
|
|
2020
Q3 | $1.27M | Buy |
+11,644
| New | +$1.27M | ﹤0.01% | 1392 |
|